The collaboration with CFA is likely to have a positive impact on Neogen's short-term performance as it opens up new marketing and educational opportunities, potentially increasing sales and market penetration for its genomic products. The partnership is directly related to Neogen's core business, and the focus on education and promotion is expected to enhance product visibility and credibility among a targeted audience.